New needle biopsy could spare women unnecessary uterus surgery
NCT ID NCT07264660
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new, less invasive biopsy method for uterine masses. The procedure uses a thin needle guided by ultrasound through the cervix to take a tissue sample. Researchers want to see if it can accurately tell benign from malignant growths, potentially helping women avoid unnecessary surgery. The study will enroll 42 women who are already scheduled for surgical removal of a uterine mass.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transcervical True-Cut Biopsy (procedure)
- What this could lead to
- If successful, this biopsy method could provide a reliable, less invasive way to diagnose uterine masses, helping many women avoid unnecessary surgery.
- What could go wrong
- This is a small, early-stage study with only 42 participants. The technique may not be accurate enough to replace current methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.